Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012, Article ID 609421, 13 pages
http://dx.doi.org/10.1155/2012/609421
Review Article

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

1Mood Disorders Program and Women's Health Concerns Clinic, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 301 James Street South, Suite F614, Hamilton, ON, Canada L8P 3B6
2Center of Oxidative Stress Research, Professor Tuiskon Dick Department of Biochemistry, Institute of Health Basic Sciences, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos Street, 2600 Anexo, 90035-003 Porto Alegre, RS, Brazil

Received 4 February 2012; Accepted 2 March 2012

Academic Editor: Daniel Pens Gelain

Copyright © 2012 Guilherme A. Behr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [94 citations]

The following is the list of published articles that have cited the current article.

  • Irena Smaga, Bartosz Pomierny, Weronika Krzyzanowska, Lucyna Pomierny-Chamiolo, Joanna Miszkiel, Ewa Niedzielska, Agata Ogórka, and Malgorzata Filip, “N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 39, no. 2, pp. 280–287, 2012. View at Publisher · View at Google Scholar
  • Hsiao-Yun Lin, Wei-Lan Yeh, Bor-Ren Huang, Chingju Lin, Chih-Ho Lai, Ho Lin, and Dah-Yuu Lu, “Desipramine Protects Neuronal Cell Death and Induces Heme Oxygenase-1 Expression in Mes23.5 Dopaminergic Neurons,” Plos One, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Franciele Donato, Marcelo Gomes de Gomes, André Tiago Rossito Goes, Natália Seus, Diego Alves, Cristiano Ricardo Jesse, and Lucielli Savegnago, “Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole,” Life Sciences, 2013. View at Publisher · View at Google Scholar
  • Luciane Costa-Campos, Ana P. Herrmann, Luísa K. Pilz, Marcus Michels, Guilherme Noetzold, and Elaine Elisabetsky, “Interactive effects of N-acetylcysteine and antidepressants,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 44, pp. 125–130, 2013. View at Publisher · View at Google Scholar
  • Luana M. Manosso, Vivian B. Neis, Morgana Moretti, Juliana F. Daufenbach, Andiara E. Freitas, André R. Colla, and Ana Lúcia S. Rodrigues, “Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013. View at Publisher · View at Google Scholar
  • W. N. Marsden, “Synaptic plasticity in depression: Molecular, cellular and functional correlates,” Progress In Neuro-Psychopharmacology & Biological Psychiatry, vol. 43, pp. 168–184, 2013. View at Publisher · View at Google Scholar
  • Joanna Rybka, Kornelia Kedziora-Kornatowska, Patrycja Banas-Lezanska, Ireneusz Majsterek, Livia A. Carvalho, Annamaria Cattaneo, Christoph Anacker, and Józef Kedziora, “Interplay between the pro-oxidant and antioxidant system, and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression,” Free Radical Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • Sawsan Aboul-Fotouh, “Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats,” Pharmacology Biochemistry and Behavior, vol. 104, pp. 105–112, 2013. View at Publisher · View at Google Scholar
  • Elvira Valera, Kiren Ubhi, Michael Mante, Edward Rockenstein, and Eliezer Masliah, “Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy,” Glia, 2013. View at Publisher · View at Google Scholar
  • Nahla E. El-Ashmawy, and Rania M. Khalil, “A review on the role of l-carnitine in the management of tamoxifen side effects in treated women with breast cancer,” Tumor Biology, 2013. View at Publisher · View at Google Scholar
  • Marcin Siwek, Magdalena Sowa-Kućma, Dominika Dudek, Krzysztof Styczeń, Bernadeta Szewczyk, Katarzyna Kotarska, Paulina Misztak, Agnieszka Pilc, Małgorzata Wolak, and Gabriel Nowak, “Oxidative stress markers in affective disorders,” Pharmacological Reports, vol. 65, no. 6, pp. 1558–1571, 2013. View at Publisher · View at Google Scholar
  • Yeshwant Kurhe, Mahesh Radhakrishnan, Deepali Gupta, and Thangaraj Devadoss, “ QCM-4 a novel 5-HT 3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice ,” Journal of Pharmacy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Luis Rafael Leite Sampaio, Marcia Calheiros Chaves Silva, Jessica Calheiros da Silva, Francisca Clea Florenco Sousa, Danielle Silveira Macedo, Suzyana Lima de Oliveira, Silvania Maria Mendes Vasconcelos, Caren Nadia Soares de Sousa, Naiara Coelho Ximenes, and Paulo Victor Pontes Araujo, “Augmentation therapy with alpha-lipoic acid and desvenlafaxine: A future target for treatment of depression?,” Naunyn-Schmiedebergs Archives Of Pharmacology, vol. 386, no. 8, pp. 685–695, 2013. View at Publisher · View at Google Scholar
  • Lucia Carboni, “Peripheral Biomarkers in Animal Models of Major Depressive Disorder,” Disease Markers, vol. 35, pp. 33–41, 2013. View at Publisher · View at Google Scholar
  • N. Jennifer Klinedinst, and William T. Regenold, “A mitochondrial bioenergetic basis of depression,” Journal of Bioenergetics and Biomembranes, 2014. View at Publisher · View at Google Scholar
  • Daniel Lindqvist, Susanne Mueller, Synthia H. Mellon, Yali Su, Elissa S. Epel, Victor I. Reus, Rebecca Rosser, Laura Mahan, R. Scott Mackin, Tony T. Yang, and Owen M. Wolkowitz, “Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls–preliminary findings,” Psychiatry Research: Neuroimaging, 2014. View at Publisher · View at Google Scholar
  • Klaus Munkholm, Henrik Enghusen Poulsen, Lars Vedel Kessing, and Maj Vinberg, “Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder,” Bipolar Disorders, 2014. View at Publisher · View at Google Scholar
  • Lauren E. Cudney, Roberto B. Sassi, Guilherme A. Behr, David L. Streiner, Luciano Minuzzi, Jose C. F. Moreira, and Benicio N. Frey, “Alterations in circadian rhythms are associated with increased lipid peroxidation in females with bipolar disorder,” International Journal of Neuropsychopharmacology, vol. 17, no. 5, pp. 715–722, 2014. View at Publisher · View at Google Scholar
  • Gyoung-Ja Lee, Sang-Kyu Lee, Ju-Myoung Kim, Chang Kyu Rhee, Yang-Kyu Lee, Kh. Z. Brainina, and Ya. E. Kazakovf, “Application Feasibility of Antioxidant Activity Evaluation Using Potentiometry in Major Depressive Disorder,” Electrochemistry, vol. 82, no. 4, pp. 264–266, 2014. View at Publisher · View at Google Scholar
  • Ibrahim Guner, Muhittin O. Yaman, Ugur Aksu, Duygu Uzun, Hayriye Erman, Meliha Inceli, Remisa Gelisken, Nermin Yelmen, Hafize Uzun, and Gulderen Sahin, “The effect of fluoxetine on ischemia-reperfusion following aortic surgery in a rat model,” Journal of Surgical Research, 2014. View at Publisher · View at Google Scholar
  • R J Park, and J D Moon, “Coffee and depression in Korea: the fifth Korean National Health and Nutrition Examination Survey,” European Journal of Clinical Nutrition, 2014. View at Publisher · View at Google Scholar
  • Catherine N. Black, Mariska Bot, Peter G. Scheffer, Pim Cuijpers, and Brenda W.J.H. Penninx, “Is depression associated with increased oxidative stress? A systematic review and meta-analysis,” Psychoneuroendocrinology, 2014. View at Publisher · View at Google Scholar
  • C. Wiener, G. T. Rassier, M. P. Kaster, K. Jansen, R. T. Pinheiro, F. Klamt, P. V. Magalhaes, F. Kapczinski, G. Ghisleni, and R. A. da Silva, “Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes,” European Psychiatry, vol. 29, no. 1, pp. 58–63, 2014. View at Publisher · View at Google Scholar
  • Samina Salim, “Oxidative stress and psychological disorders,” Current Neuropharmacology, vol. 12, no. 2, pp. 140–147, 2014. View at Publisher · View at Google Scholar
  • Piotr Gałecki, “Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders,” Medical Science Monitor, vol. 20, pp. 110–115, 2014. View at Publisher · View at Google Scholar
  • Caren Nádia Soares de Sousa, Lucas Nascimento Meneses, Germana Silva Vasconcelos, Márcia Calheiros Chaves Silva, Jéssica Calheiros da Silva, Danielle Macêdo Gaspar, David Freitas de Lucena, and Silvânia Maria Mendes Vasconcelos, “Reversal of corticosterone-induced BDNF alterations by the natural antioxidant alpha-lipoic acid alone and combined with desvenlafaxine: Emphasis on the neurotrophic hypothesis of depression,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Sagrario Martín-Aragón, Ángel Villar, and Juana Benedí, “Age-dependent effects of esculetin on mood-related behavior and cognition from stressed mice are associated with restoring brain antioxidant status,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Zhuo-Jun Tang, Wei Zou, Juan Yuan, Ping Zhang, Ying Tian, Zhi-Fang Xiao, Mang-Hong Li, Hai-Jun Wei, and Xiao-Qing Tang, “Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in streptozotocin-induced diabetic rats through inhibition of hippocampal oxidative stress,” Behavioural Pharmacology, vol. 26, no. 5, pp. 427–435, 2015. View at Publisher · View at Google Scholar
  • Fernanda N. Kaufmann, Marta Gazal, Thaíse C. Mondin, Taiane A. Cardoso, Luciana de Ávila Quevedo, Luciano Dias de Mattos Souza, Karen Jansen, Elizandra Braganhol, Jean Pierre Oses, Ricardo Tavares Pinheiro, Manuella Pinto Kaster, Ricardo Azevedo Silva, and Gabriele Ghisleni, “Cognitive psychotherapy treatment decreases peripheral oxidative stress parameters associated with major depression disorder,” Biological Psychology, 2015. View at Publisher · View at Google Scholar
  • Yunes Panahi, Roghayeh Badeli, Gholam-Reza Karami, Zeinab Badeli, and Amirhossein Sahebkar, “A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder,” Complementary Therapies in Medicine, vol. 23, no. 4, pp. 598–602, 2015. View at Publisher · View at Google Scholar
  • Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Michael Berk, Olivia Dean, Charles Spielholz, and Richard Frye, “Clinical Trials of N-acetylcysteine in Psychiatry and Neurology: A Systematic Review,” Neuroscience & Biobehavioral Reviews, 2015. View at Publisher · View at Google Scholar
  • Indira Mendez-David, Laurent Tritschler, Zeina El Ali, Marie-Hélène Damiens, Marc Pallardy, Denis J. David, Saadia Kerdine-Römer, and Alain M. Gardier, “Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression,” Neuroscience Letters, 2015. View at Publisher · View at Google Scholar
  • Monika Talarowska, Janusz Szemraj, Michael Berk, Michael Maes, and Piotr Galecki, “Oxidant/antioxidant imbalance is an inherent feature of depression,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Nataliia Bakunina, Carmine M. Pariante, and Patricia A. Zunszain, “Immune mechanisms linked to depression via oxidative stress and neuroprogression,” Immunology, vol. 144, no. 3, pp. 365–373, 2015. View at Publisher · View at Google Scholar
  • Ali Talaei, Maryam Hassanpour Moghadam, Sayyed Abolghasem Sajadi Tabassi, and Seyed Ahmad Mohajeri, “Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, ,” Journal Of Affective Disorders, vol. 174, pp. 51–56, 2015. View at Publisher · View at Google Scholar
  • Ankur Jindal, Radhakrishnan Mahesh, and Shvetank Bhatt, “Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological defici,” Psychopharmacology, vol. 232, no. 3, pp. 623–637, 2015. View at Publisher · View at Google Scholar
  • Ankur Jindal, Radhakrishnan Mahesh, and Shvetank Bhatt, “Type 4 Phosphodiesterase Enzyme Inhibitor, Rolipram Rescues Behavioral Deficits in Olfactory Bulbectomy Models of Depression: Involvement of Hypothalamic-Pituitary-Adrenal Axis, cAMP Signaling Aspects and Antioxidant Defense System,” Pharmacology Biochemistry and Behavior, 2015. View at Publisher · View at Google Scholar
  • Aline Haas de Mello, Luana da Rosa Souza, Ana Carla Moreira Cereja, Rosiane de Bona Schraiber, Drielly Florentino, Maryane Modolon Martins, Fabricia Petronilho, João Quevedo, and Gislaine Tezza Rezin, “Effect of subchronic administration of agomelatine on brain energy metabolism and oxidative stress parameters in rats,” Psychiatry and Clinical Neurosciences, vol. 70, no. 4, pp. 159–166, 2015. View at Publisher · View at Google Scholar
  • Juliana Lenzi, Andre Felipe Rodrigues, Adriana de Sousa Ros, Bianca Blanski de Castro, Daniela Delwing de Lima, Debora Delwing Dal Magro, and Ana Lucia Bertarello Zeni, “Ferulic acid chronic treatment exerts antidepressant-like effect: role of antioxidant defense system,” Metabolic Brain Disease, vol. 30, no. 6, pp. 1453–1463, 2015. View at Publisher · View at Google Scholar
  • Lucimar M. Pinto Brod, Mariana G. Fronza, Jaqueline Pinto Vargas, Diogo Ludtke, Cristiane Luchese, Ethel Antunes Wilhelm, and Lucielli Savegnago, “Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Cheng-Chen Chang, Chun-Te Lee, Tsuo-Hung Lan, Po-Chung Ju, Yi-Hsien Hsieh, and Te-Jen Lai, “Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Hye-In Woo, Mi-Ryung Chun, Jeong-Soo Yang, Shinn-Won Lim, Min-Ji Kim, Seon-Woo Kim, WooJae Myung, Doh-Kwan Kim, and Soo-Youn Lee, “Plasma Amino Acid Profiling in Major Depressive Disorder Treated With Selective Serotonin Reuptake Inhibitors,” CNS Neuroscience & Therapeutics, 2015. View at Publisher · View at Google Scholar
  • Sukhneeraj Pal Kaur, Seema Bansal, and Kanwaljit Chopra, “17α-Estradiol: A candidate neuroserm and non-feminizing estrogen for postmenopausal neuronal complications,” Steroids, 2015. View at Publisher · View at Google Scholar
  • Hayriye Erman, Ibrahim Guner, Muhittin Onur Yaman, Duygu Derya Uzun, Remise Gelisgen, Ugur Aksu, Nermin Yelmen, Gulderen Sahin, and Hafize Uzun, “The effects of fluoxetine on circulating oxidative damage parameters in rats exposed to aortic ischemia-reperfusion,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Jay P. Patel, and Benicio N. Frey, “Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?,” Neural Plasticity, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Magdaléna Vaváková, Zdeňka Ďuračková, and Jana Trebatická, “Markers of Oxidative Stress and Neuroprogression in Depression Disorder,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Graham Mazereeuw, Nathan Herrmann, Ana C Andreazza, Maisha M Khan, and Krista L Lanctôt, “A meta-analysis of lipid peroxidation markers in major depression.,” Neuropsychiatric disease and treatment, vol. 11, pp. 2479–91, 2015. View at Publisher · View at Google Scholar
  • Esraa A. Kandil, Noha F. Abdelkader, Bahia M. El-Sayeh, and Samira Saleh, “Imipramine and Amitriptyline Ameliorate the Rotenone Model of Parkinson’s Disease in Rats,” Neuroscience, 2016. View at Publisher · View at Google Scholar
  • Danielle Santana-Coelho, José Rogerio Souza-Monteiro, Ricardo S.O. Paraense, Guilherme L. Busanello, Gabriela P.F. Arrifano, Jackson R. Mendonça, Mauro E.P. Silveira-Junior, Luiz Fernando F. Royes, and Maria Elena Crespo-López, “Antidepressant drugs in convulsive seizures: Pre-clinical evaluation of duloxetine in mice,” Neurochemistry International, 2016. View at Publisher · View at Google Scholar
  • J Ernst, A Hock, A Henning, E Seifritz, H Boeker, and S Grimm, “Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder,” Molecular Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Deepali Gupta, Visakh Prabhakar, and Mahesh Radhakrishnan, “5HT3 receptors: Target for new antidepressant drugs,” Neuroscience & Biobehavioral Reviews, vol. 64, pp. 311–325, 2016. View at Publisher · View at Google Scholar
  • Jin-Fang Ge, Ya-Yun Xu, Gan Qin, Jiang-Qun Cheng, and Fei-Hu Chen, “Resveratrol Ameliorates the Anxiety- and Depression-Like Behavior of Subclinical Hypothyroidism Rat: Possible Involvement of the HPT Axis, HPA Axis, and Wnt/β-Catenin Pathway,” Frontiers in Endocrinology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Muhammad Ummear Raza, Turan Tufan, Yan Wang, Christopher Hill, and Meng-Yang Zhu, “DNA Damage in Major Psychiatric Diseases,” Neurotoxicity Research, 2016. View at Publisher · View at Google Scholar
  • Alaleh Soltanian, Javad Khoshnegah, and Mohammad Heidarpour, “Comparison of serum trace elements and antioxidant levels in terrier dogs with or without behavior problems,” Applied Animal Behaviour Science, 2016. View at Publisher · View at Google Scholar
  • Nidhika Sharma, Sumit Jamwal, and Puneet Kumar, “Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats,” Pathophysiology, 2016. View at Publisher · View at Google Scholar
  • Longfei Wang, Xiaoli Shen, Yili Wu, and Dongfeng Zhang, “Coffee and caffeine consumption and depression: A meta-analysis of observational studies,” Australian And New Zealand Journal Of Psychiatry, vol. 50, no. 3, pp. 228–242, 2016. View at Publisher · View at Google Scholar
  • Marwa M. Al-Samhari, Nouf M. Al-Rasheed, Salim Al-Rejaie, Nawal M. Al-Rasheed, Iman H. Hasan, Ayman M. Mahmoud, and Nduna Dzimiri, “Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects,” Experimental Biology And Medicine, vol. 241, no. 5, pp. 509–518, 2016. View at Publisher · View at Google Scholar
  • Ahmed M. Kabel, and Abeer A. Elkhoely, “Ameliorative potential of fluoxetine/raloxifene combination on experimentally induced breast cancer,” Tissue and Cell, 2016. View at Publisher · View at Google Scholar
  • Daniel Lindqvist, Firdaus S. Dhabhar, S. Jill James, Christina M. Hough, Felipe A. Jain, F. Saverio Bersani, Victor I. Reus, Josine E. Verhoeven, Elissa S. Epel, Laura Mahan, Rebecca Rosser, Owen M. Wolkowitz, and Synthia H. Mellon, “Oxidative stress, inflammation and treatment response in major depression,” Psychoneuroendocrinology, 2016. View at Publisher · View at Google Scholar
  • S. Salim, “Oxidative Stress and the Central Nervous System,” Journal of Pharmacology and Experimental Therapeutics, vol. 360, no. 1, pp. 201–205, 2016. View at Publisher · View at Google Scholar
  • Joanna Robaczewska, Kornelia Kędziora-Kornatowska, Robert Kucharski, Maria Nowak, Marta Muszalik, Maciej Kornatowski, and Józef Kędziora, “Decreased expression of heme oxygenase is associated with depressive symptoms and may contribute to depressive and hypertensive comorbidity,” Redox Report, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Caroline F. Ortmann, Gislaine Z. Réus, Zuleide M. Ignácio, Helena M. Abelaira, Stephanie E. Titus, Pâmela de Carvalho, Camila O. Arent, Maria Augusta B. dos Santos, Beatriz I. Matias, Maryane M. Martins, Angela M. de Campos, Fabricia Petronilho, Leticia J. Teixeira, Meline O. S. Morais, Emilio L. Streck, João Quevedo, and Flávio H. Reginatto, “Enriched Flavonoid Fraction from Cecropia pachystachya Trécul Leaves Exerts Antidepressant-like Behavior and Protects Brain Against Oxidative Stress in Rats Subjected to Chronic Mild Stress,” Neurotoxicity Research, 2016. View at Publisher · View at Google Scholar
  • Lara S.F. Carneiro, António Manuel Fonseca, Paula Serrão, Maria Paula Mota, José Vasconcelos-Raposo, and Maria Augusta Vieira-Coelho, “Impact of physical exercise on catechol-O-methyltransferase activity in depressive patients: A preliminary communication,” Journal of Affective Disorders, 2016. View at Publisher · View at Google Scholar
  • Marcin Siwek, Magdalena Sowa-Kucma, Krzysztof Styczen, Paulina Misztak, Bernadeta Szewczyk, Roman Topor-Madry, Gabriel Nowak, Dominika Dudek, and Janusz K. Rybakowski, “Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder,” Neuropsychobiology, vol. 73, no. 2, pp. 116–122, 2016. View at Publisher · View at Google Scholar
  • Ioana Miruna Balmus, Alin Ciobica, Iulia Antioch, Romeo Dobrin, and Daniel Timofte, “Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches,” Oxidative Medicine and Cellular Longevity, vol. 2016, pp. 1–25, 2016. View at Publisher · View at Google Scholar
  • Onur M. Yaman, Hayriye Erman, Ibrahim Guner, Olgu Enis Tok, Mukaddes Pala, Mukaddes Esrefoglu, Remise Gelisgen, Hafize Uzun, Ugur Aksu, Nermin Yelmen, and Gulderen Sahin, “Remote myocardial injury: the protective role of fluoxetine,” Canadian Journal of Physiology and Pharmacology, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Redouane Rebai, Luc Jasmin, and Abdennacer Boudah, “The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices,” Brain Research Bulletin, 2017. View at Publisher · View at Google Scholar
  • Adaeze Adebesin, Olusegun A. Adeoluwa, Anthony T. Eduviere, and Solomon Umukoro, “Methyl jasmonate attenuated lipopoysaccharide-induced depressive-like behaviour in mice,” Journal of Psychiatric Research, 2017. View at Publisher · View at Google Scholar
  • Nevena Todorović, and Dragana Filipović, “Prefrontal cortical glutathione-dependent defense and proinflammatory mediators in chronically isolated rats: modulation by fluoxetine or clozapine,” Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Caroline Flach Ortmann, Helena Mendes Abelaira, Gislaine Zilli Réus, Zuleide Maria Ignácio, Vitor Clasen Chaves, Talitha Caldas dos Santos, Pâmela de Carvalho, Anelise Scussel Carlessi, Livia Bruchchen, Lucineia G. Danielski, Simone Gonçalves Cardoso, Angela Machado de Campos, Fabricia Petronilho, Joyce Rebelo, Meline Oliveira dos Santos Morais, Francieli Vuolo, Felipe Dal-Pizzol, Emilio Luiz Streck, João Quevedo, and Flávio Henrique Reginatto, “ LC/QTOF profile and preliminary stability studies of an enriched flavonoid fraction of Cecropia pachystachya Trécul leaves with potential antidepressant-like activity ,” Biomedical Chromatography, pp. e3982, 2017. View at Publisher · View at Google Scholar
  • De L. T. Giovana Vieira, Amy C. Lossie, Donald C. Lay, John S. Radcliffe, and Joseph P. Garner, “Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of Trichotillomania,” PLoS ONE, vol. 12, no. 4, 2017. View at Publisher · View at Google Scholar
  • Maria Daglia, Arianna Di Lorenzo, Seyed Fazel Nabavi, Antoni Sureda, Sedigheh Khanjani, Akbar Hajizadeh Moghaddam, Nady Braidy, and Seyed Mohammad Nabavi, “Improvement of Antioxidant Defences and Mood Status by Oral GABA Tea Administration in a Mouse Model of Post-Stroke Depression,” Nutrients, vol. 9, no. 5, pp. 446, 2017. View at Publisher · View at Google Scholar
  • Jovana Joksimović, Dragica Selaković, Vladimir Jakovljević, Vladimir Mihailović, Jelena Katanić, Tatjana Boroja, and Gvozden Rosić, “Alterations of the oxidative status in rat hippocampus and prodepressant effect of chronic testosterone enanthate administration,” Molecular and Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Ewa A. Ogłodek, “The Role of PON-1, GR, IL-18, and oxLDL in Depression With and Without Posttraumatic Stress Disorder,” Pharmacological Reports, 2017. View at Publisher · View at Google Scholar
  • Rachel D Freed, Cecilia N Hollenhorst, Nora Weiduschat, Xiangling Mao, Guoxin Kang, Dikoma C Shungu, and Vilma Gabbay, “A pilot study of cortical glutathione in youth with depression.,” Psychiatry research, vol. 270, pp. 54–60, 2017. View at Publisher · View at Google Scholar
  • Zuleide Maria Ignácio, Ana Valquíria Calixto, Ritele Hernandez da Silva, João Quevedo, and Gislaine Zilli Réus, “The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies,” Neuroscience & Biobehavioral Reviews, 2017. View at Publisher · View at Google Scholar
  • Daiane Fátima Engel, Jade de Oliveira, Vicente Lieberknecht, Ana Lucia Severo Rodrigues, Andreza Fabro de Bem, and Nelson Horácio Gabilan, “Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway,” Neurochemical Research, 2017. View at Publisher · View at Google Scholar
  • Siu W. Tang, Wayne H. Tang, and Brain E. Leonard, “Multitarget botanical pharmacotherapy in major depression,” International Clinical Psychopharmacology, vol. 32, no. 6, pp. 299–308, 2017. View at Publisher · View at Google Scholar
  • Zhang-Peng Shi, Qing Dong, and Ming-Cang Chen, “Mitochondrial abnormality in major depressive disorder: Research advances,” Journal of International Pharmaceutical Research, vol. 44, no. 1, pp. 30–34, 2017. View at Publisher · View at Google Scholar
  • Mariana G Fronza, Lucimar M Pinto Brod, Angela Maria Casaril, Manoela Sacramento, Diego Alves, and Lucielli Savegnago, “Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice.,” PloS one, vol. 12, no. 11, 2017. View at Publisher · View at Google Scholar
  • Nebal El Tanbouly, Abeer Mohamed El Sayed, Zeinab Y. Ali, Samia Abdel Wahab, Sabah H. El Gayed, Shahira M. Ezzat, Amira Safwat El Senousy, Mouchira A. Choucry, and Essam Abdel-Sattar, “Antidepressant-Like Effect of Selected Egyptian Cultivars of Flaxseed Oil on a Rodent Model of Postpartum Depression,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–15, 2017. View at Publisher · View at Google Scholar
  • Ana B. Ramos-Hryb, Mauricio P. Cunha, Manuella P. Kaster, and Ana Lúcia S. Rodrigues, “Natural Polyphenols and Terpenoids for Depression Treatment: Current Status,” vol. 55, pp. 181–221, 2017. View at Publisher · View at Google Scholar
  • Jiwon Kim, and Jihye Kim, “Green Tea, Coffee, and Caffeine Consumption Are Inversely Associated with Self-Report Lifetime Depression in the Korean Population,” Nutrients, vol. 10, no. 9, pp. 1201, 2018. View at Publisher · View at Google Scholar
  • Marwa M. Sherkawy, Amira M. Abo-youssef, Abeer A.A. Salama, and Ismaiel E. Ismaiel, “Fluoxetine protects against OVA induced bronchial asthma and depression in rats,” European Journal of Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Jitendra Jeenger, Devendra Mohan Mathur, Vikas Singroha, and Manu Sharma, “C-reactive protein, brain-derived neurotrophic factor, interleukin-2, and stressful life events in drug-naive first-episode and recurrent depression: A cross-sectional study,” Indian Journal of Psychiatry, vol. 60, no. 3, pp. 334–339, 2018. View at Publisher · View at Google Scholar
  • Ting Wu, Tingting Li, Xiangting Li, Jingsi Zhang, Wen Zhang, Jun Xiang, Dingfang Cai, Zhonghai Yu, Zhennian Zhang, and Min Cai, “Apocynum venetum leaf extract reverses depressive-like behaviors in chronically stressed rats by inhibiting oxidative stress and apoptosis,” Biomedicine and Pharmacotherapy, vol. 100, pp. 394–406, 2018. View at Publisher · View at Google Scholar
  • Dami Kang, Youngyo Kim, and Youjin Je, “Non-alcoholic beverage consumption and risk of depression: epidemiological evidence from observational studies,” European Journal of Clinical Nutrition, 2018. View at Publisher · View at Google Scholar
  • Sally A. Abuelezz, and Nevien Hendawy, “Insights into the potential antidepressant mechanisms of cilostazol in chronically restraint rats,” Behavioural Pharmacology, vol. 29, no. 1, pp. 28–40, 2018. View at Publisher · View at Google Scholar
  • Mariola Herbet, Aleksandra Szopa, Anna Serefko, Sylwia Wośko, Monika Gawrońska-Grzywacz, Magdalena Izdebska, Iwona Piątkowska-Chmiel, Paulina Betiuk, Ewa Poleszak, and Jarosław Dudka, “8-cyclopentyl-1,3-dimethylxanthine enhances effectiveness of antidepressant in behavioral tests and modulates redox balance in the cerebral cortex of mice,” Saudi Pharmaceutical Journal, 2018. View at Publisher · View at Google Scholar
  • Yasser A. Khadrawy, Hussein G. Sawie, Eman N. Hosny, and Hagar H. Mourad, “Assessment of the antidepressant effect of caffeine using rat model of depression induced by reserpine,” Bulletin of the National Research Centre, vol. 42, no. 1, 2018. View at Publisher · View at Google Scholar
  • Mete Ozcan, Sinan Canpolat, Ozgur Bulmus, Nazife Ulker, Ahmet Tektemur, Suat Tekin, Sibel Ozcan, Ihsan Serhatlioglu, Emine Kacar, Ahmet Ayar, and Haluk Kelestimur, “Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice,” Fundamental & Clinical Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Deepali Gupta, and Radhakrishnan Maheshvol. 2, pp. 235–249, 2018. View at Publisher · View at Google Scholar
  • George Anderson, and Michael Maes, “The Biological Underpinnings of Mood Disorders Interact With Early Trauma, Sexual Abuse and Neuroticism: Implications for Psychiatric Classification and Treatment,” Inflammation and Immunity in Depression, pp. 549–567, 2018. View at Publisher · View at Google Scholar
  • Adrian L. Lopresti, “Mitochondrial Dysfunction and Oxidative Stress: Relevance to the Pathophysiology and Treatment of Depression,” Neurobiology of Depression, pp. 159–168, 2019. View at Publisher · View at Google Scholar